Fluid Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Fluid Therapy Market: By Fluid Type (Colloids, Crystalloids, Blood And Blood Products, and Others.), Application (Urology and Nephrology, Laparoscopy, Gastroenterology, Gynecology, Bronchoscopy, Arthroscopy, Cardiology, Neurology, Otoscopy, Dentistry, and Other), Fluid Administration (Oral, Subcutaneous, Intravenous, Intraosseous, Intraperitoneal And Others), End Users (Hospitals, Dialysis Centers, Ambulatory Surgical Centers, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa) and Forecast to 2028

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

The Fluid Therapy Market size was valued at USD 10,212 million in 2021 which is expected to grow at a CAGR of 6.2% from 2022-2028. Fluid Therapy is a type of therapy that includes inoculation of the crystalloid mixture into patients whose circulating blood volume is decreased. This therapy can also be used for treating dehydration to substitute the fluid loss from the body. This therapy helps to meet the fluid requirements for those patients who cannot take fluids orally. The increasing prevalence of infectious and chronic diseases such as cancer, gastrointestinal tract, nephrology, and diabetes and the increasing number of minor invasive surgeries are some primary factors that can boost the global fluid therapy market. Apart from this, an increase in health consciousness among individuals, and expansion in marketable pipelines can also accelerate the market in the future. Another factor that drives the fluid therapy market is the growing research and development in pharmaceutical and biotechnological industries to come up with new treatment methods for certain diseases such as sepsis, hypovolemia, colic and shock, and the launch of novel services and products. Moreover, technological advancement and an increase in healthcare expenditure can future drive market growth. However, some factors such as the high purchasing cost of fluid therapy instruments, lack of technical skills, and lack of awareness about this therapy among the population can restrain the growth of the market. Another factor that can hinder the growth of the market is concern about plastic bags releasing toxic chemicals into the veins of the patient. Moreover, the usage of single-use disposable accessories and devices and the developing market are expected to produce lucrative opportunities for the global market.

Recent Market Developments:

In June 2020, Fresenius Medical care planned to open more than 100 new transitional care units in the US to empower people with kidney diagnosis, home dialysis, and treatment.

In December 2020, a Carpediem System, a neonatal and pediatric acute dialysis machine, was launched by Medtronic.

Fluid Therapy Market

MARKET SUMMARY
-
6.2% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.2%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Fluid Therapy Market

  • The report on fluid therapy market gives historical, current, and future market sizes (US$ Bn) on the basis of fluid type, application, fluid administration, end user and geography.
  • The fluid therapy market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Animalcare
  • Baxter
  • DJ labs
  • ICU Medical Inc.
  • Braun Melsungen AG
Fluid Therapy Market Dynamics

One of the major reasons for the growth of the global fluid therapy market is the growing number of minor invasive surgeries. Minor surgeries have a variety of advantages over open surgeries such as rapid recovery periods, fewer postoperative problems, and lower danger of infection at the surgical site. These surgeries are also called outpatient surgeries as the patient does not have to stay overnight in the medical centers. Minimal invasive surgeries are done for the colon, appendix, and lungs. Moreover, these surgeries are covered by medical insurance companies across the globe which makes them even more popular. Thus, the increasing number of minor invasive surgeries for cancer treatment can accelerate the demand for the fluid therapy market in the future.


North-America Got Significant Share

Fluid Therapy Market

North America is dominating the global fluid therapy market, due to the growing prevalence of chronic diseases such as cancer, and gastrointestinal diseases, and the increase in the geriatric populace that increases the demand for intravenous solutions. Another reason for the growth of fluid therapy in the North American market is the presence of key players in this region that have contributed to meeting the increasing demand during the pandemic or the flu. In addition, Asia Pacific is one of the profitable regions and is generating new prospects for global players. For instance, in some countries such as India and China, the government has taken initiatives to improve laboratory infrastructure which has the potential to increase the demand for fluid therapy in these regions. Apart from this, the growing prevalence of chronic diseases due to unhealthy diet and increasing demand for inexpensive treatment can have lucrative opportunities.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The fluid therapy market report provides granular level information about the market size, regional market share and forecast from 2022-2028
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Fluid Therapy Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The fluid therapy market is projected to expand at a CAGR of 6.2% during the forecast period

Fresenius Kabi AG, Dechra Veterinary Products, LLC, DJ labs, B. Braun Melsungen AG, Baxter, Animalcare, ICU Medical Inc.

North America is the fastest-growing region for fluid therapy market


Report

Table Of Content

1. Executive Summary
2. Global Fluid Therapy Market Introduction
2.1. Global Fluid Therapy Market – Taxonomy
2.2. Global Fluid Therapy Market –Definitions
2.2.1. Fluid Type
2.2.2. Application
2.2.3. Fluid Adminstration
2.2.4. End User
2.2.5. By Region
3. Global Fluid Therapy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Fluid Therapy Market Dynamic Factors – Impact Analysis
3.6. Global Fluid Therapy Market – Competition Landscape
3.7. Epidemiology
4. Global Fluid Therapy Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Fluid Therapy Market, By Fluid Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Colloids
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Crystalloids
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Blood
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Blood Products
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Fluid Therapy Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Urology and Nephrology
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Laparoscopy
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Gastroenterology
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Gynecology / Obstetrics
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Bronchoscopy
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Arthroscopy
6.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Cardiology
6.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Neurology
6.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
6.9. Otoscopy
6.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.9.3. Market Opportunity Analysis
6.10. Dentistry
6.10.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.10.3. Market Opportunity Analysis
6.11. Others
6.11.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.11.3. Market Opportunity Analysis
7. Global Fluid Therapy Market, By Fluid Administration, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Oral
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Subcutaneous
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Intravenous
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Intraosseous
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Intraperitoneal
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Fluid Therapy Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Hospitals
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Dialysis Centers
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Ambulatory Surgical Centers
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Other
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Fluid Therapy Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Fluid Therapy Market – Opportunity Analysis Index, By Fluid Type, ByFluid Administration, By Application, By End User, and Region, 2022-2028
10. North America Fluid Therapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Fluid Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Colloids
10.1.2. Crystalloids
10.1.3. Blood
10.1.4. BloodProducts
10.1.5. Others
10.2. Fluid Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Oral
10.2.2. Subcutaneous
10.2.3. Intravenous
10.2.4. Intraosseous
10.2.5. Intraperitoneal
10.2.6. Others
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Urology and Nephrology
10.3.2. Laparoscopy
10.3.3. Gastroenterology
10.3.4. Gynecology / Obstetrics
10.3.5. Bronchoscopy
10.3.6. Arthroscopy
10.3.7. Cardiology
10.3.8. Neurology
10.3.9. Otoscopy
10.3.10. Dentistry
10.3.11. Other
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospitals
10.4.2. Dialysis Centers
10.4.3. Ambulatory Surgical Centers
10.4.4. Other
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Fluid Therapy Market – Opportunity Analysis Index, By Fluid Type, By Fluid Administration, By Application, By End User, and Country, 2022-2028
10.7. North America Fluid Therapy Market Dynamics – Trends
11. Europe Fluid Therapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Fluid Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Colloids
11.1.2. Crystalloids
11.1.3. Blood
11.1.4. BloodProducts
11.1.5. Others
11.2. Fluid Admiration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Oral
11.2.2. Subcutaneous
11.2.3. Intravenous
11.2.4. Intraosseous
11.2.5. Intraperitoneal
11.2.6. Others
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Urology and Nephrology
11.3.2. Laparoscopy
11.3.3. Gastroenterology
11.3.4. Gynecology / Obstetrics
11.3.5. Bronchoscopy
11.3.6. Arthroscopy
11.3.7. Cardiology
11.3.8. Neurology
11.3.9. Otoscopy
11.3.10. Dentistry
11.3.11. Other
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospitals
11.4.2. Dialysis Centers
11.4.3. Ambulatory Surgical Centers
11.4.4. Other
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Fluid Therapy Market – Opportunity Analysis Index, By Fluid Type, ByFluid Administration, By Application, By End User, and Country, 2022-2028
11.7. Europe Fluid Therapy Market Dynamics – Trends
12. Asia-Pacific Fluid Therapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Fluid Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Colloids
12.1.2. Crystalloids
12.1.3. Blood
12.1.4. BloodProducts
12.1.5. Others
12.2. Fluid Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Oral
12.2.2. Subcutaneous
12.2.3. Intravenous
12.2.4. Intraosseous
12.2.5. Intraperitoneal
12.2.6. Others
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Urology and Nephrology
12.3.2. Laparoscopy
12.3.3. Gastroenterology
12.3.4. Gynecology / Obstetrics
12.3.5. Bronchoscopy
12.3.6. Arthroscopy
12.3.7. Cardiology
12.3.8. Neurology
12.3.9. Otoscopy
12.3.10. Dentistry
12.3.11. Other
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospitals
12.4.2. Dialysis Centers
12.4.3. Ambulatory Surgical Centers
12.4.4. Other
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Fluid Therapy Market – Opportunity Analysis Index, By Fluid Type, By Fluid Administration, By Application, By End User, and Country, 2022-2028
12.7. Asia-Pacific Fluid Therapy Market Dynamics – Trends
13. Latin America Fluid Therapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Fluid Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Colloids
13.1.2. Crystalloids
13.1.3. Blood
13.1.4. BloodProducts
13.1.5. Others
13.2. Fluid Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Oral
13.2.2. Subcutaneous
13.2.3. Intravenous
13.2.4. Intraosseous
13.2.5. Intraperitoneal
13.2.6. Others
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Urology and Nephrology
13.3.2. Laparoscopy
13.3.3. Gastroenterology
13.3.4. Gynecology / Obstetrics
13.3.5. Bronchoscopy
13.3.6. Arthroscopy
13.3.7. Cardiology
13.3.8. Neurology
13.3.9. Otoscopy
13.3.10. Dentistry
13.3.11. Other
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals
13.4.2. Dialysis Centers
13.4.3. Ambulatory Surgical Centers
13.4.4. Other
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Fluid Therapy Market – Opportunity Analysis Index, By Fluid Type, By Fluid Administration, By Application, By End User, and Country, 2022-2028
13.7. Latin America Fluid Therapy Market Dynamics – Trends
14. Middle East and Africa Fluid Therapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Fluid Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Colloids
14.1.2. Crystalloids
14.1.3. Blood
14.1.4. BloodProducts
14.1.5. Others
14.2. Fluid Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Oral
14.2.2. Subcutaneous
14.2.3. Intravenous
14.2.4. Intraosseous
14.2.5. Intraperitoneal
14.2.6. Others
14.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Urology and Nephrology
14.3.2. Laparoscopy
14.3.3. Gastroenterology
14.3.4. Gynecology / Obstetrics
14.3.5. Bronchoscopy
14.3.6. Arthroscopy
14.3.7. Cardiology
14.3.8. Neurology
14.3.9. Otoscopy
14.3.10. Dentistry
14.3.11. Other
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals
14.4.2. Dialysis Centers
14.4.3. Ambulatory Surgical Centers
14.4.4. Other
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Fluid Therapy Market- Opportunity Analysis Index, By Fluid Type, By Fluid Administration, By Application, By End User, and Country, 2022-2028
14.7. MEA Fluid Therapy Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Fluid Types, Key Developments, Strategies, and SWOT Analysis)
15.2.1.1. Fresenius Kabi AG
15.2.1.2. Dechra Veterinary Products, LLC
15.2.1.3. DJ labs
15.2.1.4. B. Braun Melsungen AG
15.2.1.5. Baxter
15.2.1.6. Animalcare
15.2.1.7. ICU Medical Inc.
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Fresenius Kabi AG
  • Dechra Veterinary Products, LLC
  • DJ labs
  • Braun Melsungen AG
  • Baxter
  • Animalcare
  • ICU Medical Inc.

Description

The Fluid Therapy Market size was valued at USD 10,212 million in 2021 which is expected to grow at a CAGR of 6.2% from 2022-2028. Fluid Therapy is a type of therapy that includes inoculation of the crystalloid mixture into patients whose circulating blood volume is decreased. This therapy can also be used for treating dehydration to substitute the fluid loss from the body. This therapy helps to meet the fluid requirements for those patients who cannot take fluids orally. The increasing prevalence of infectious and chronic diseases such as cancer, gastrointestinal tract, nephrology, and diabetes and the increasing number of minor invasive surgeries are some primary factors that can boost the global fluid therapy market. Apart from this, an increase in health consciousness among individuals, and expansion in marketable pipelines can also accelerate the market in the future. Another factor that drives the fluid therapy market is the growing research and development in pharmaceutical and biotechnological industries to come up with new treatment methods for certain diseases such as sepsis, hypovolemia, colic and shock, and the launch of novel services and products. Moreover, technological advancement and an increase in healthcare expenditure can future drive market growth. However, some factors such as the high purchasing cost of fluid therapy instruments, lack of technical skills, and lack of awareness about this therapy among the population can restrain the growth of the market. Another factor that can hinder the growth of the market is concern about plastic bags releasing toxic chemicals into the veins of the patient. Moreover, the usage of single-use disposable accessories and devices and the developing market are expected to produce lucrative opportunities for the global market.

Recent Market Developments:

In June 2020, Fresenius Medical care planned to open more than 100 new transitional care units in the US to empower people with kidney diagnosis, home dialysis, and treatment.

In December 2020, a Carpediem System, a neonatal and pediatric acute dialysis machine, was launched by Medtronic.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX